The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment.
about
Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to DateOverexpression of Homer1a in the basal and lateral amygdala impairs fear conditioning and induces an autism-like social impairmentDynamic changes in extracellular release of GABA and glutamate in the lateral septum during social play behavior in juvenile rats: Implications for sex-specific regulation of social play behavior.Neurophysiological hyperresponsivity to sensory input in autism spectrum disorders.Enrichment of mutations in chromatin regulators in people with Rett syndrome lacking mutations in MECP2.Translational potential of astrocytes in brain disorders.Neuroimaging with magnetoencephalography: A dynamic view of brain pathophysiology.Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature.Methylphenidate Increases Glutamate Uptake in Bergmann Glial Cells.Transgenerational transmission and modification of pathological traits induced by prenatal immune activation.Cross Talk: The Microbiota and Neurodevelopmental Disorders.An autism spectrum disorder-related de novo mutation hotspot discovered in the GEF1 domain of TrioNeural Hyperexcitability in Autism Spectrum Disorders.Decreased plasma agmatine levels in autistic subjects.Gene-set analysis shows association between FMRP targets and autism spectrum disorder.Dietary Considerations in Autism Spectrum Disorders: The Potential Role of Protein Digestion and Microbial Putrefaction in the Gut-Brain Axis.Autism spectrum disorder: prospects for treatment using gene therapy.Induced pluripotent stem cells as a tool to study brain circuits in autism-related disorders
P2860
Q27025683-72194350-3852-49F6-9A1E-73613F8F260AQ27322939-62EFA741-EF2E-497B-A570-77EAA08CE5B7Q28266736-5D2709F1-E22A-4D81-AB0F-0287C6329F24Q30376849-BBEC8FAE-7BCD-4098-86D9-4D6BBADC224CQ37410689-0F15BD8F-5A80-4755-A679-91A2B45FDA02Q38589482-89E212D3-C62D-4207-A45C-FFE51762A6F5Q38732228-41EEB5E5-DEC3-48EC-B580-20F018554A19Q38816381-86E41763-0467-4B78-B0D9-07B70C4B7898Q38834254-398E8181-1403-48E4-8204-CBFE7AF9F79BQ40737834-A0A0FC25-7749-4F91-84A2-E74D57FF39F1Q41665354-56FB0BDF-B19A-45ED-98A0-3096BE8FC80EQ41701173-E0803362-49F0-4B05-9B2A-1C7E31832EC7Q47136579-4F993D71-7857-4EC8-AF2E-57D9B71B8013Q47663697-34D52802-8E28-44C6-82DC-964A077D9D5DQ47745129-F57B6C75-03B6-4B17-91FB-DF3305D5BE8EQ54958844-704F0ECD-4E65-420D-B139-B593E153F422Q55339450-E99FEF67-D434-4CEC-869F-93AAFA6FAB02Q58714041-F5B42B4F-B358-4E75-9188-64D23B2E53BC
P2860
The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The role of glutamate and its ...... eptor antagonists in treatment
@nl
The role of glutamate and its ...... ptor antagonists in treatment.
@ast
The role of glutamate and its ...... ptor antagonists in treatment.
@en
type
label
The role of glutamate and its ...... eptor antagonists in treatment
@nl
The role of glutamate and its ...... ptor antagonists in treatment.
@ast
The role of glutamate and its ...... ptor antagonists in treatment.
@en
prefLabel
The role of glutamate and its ...... eptor antagonists in treatment
@nl
The role of glutamate and its ...... ptor antagonists in treatment.
@ast
The role of glutamate and its ...... ptor antagonists in treatment.
@en
P2860
P3181
P1476
The role of glutamate and its ...... ptor antagonists in treatment.
@en
P2860
P2888
P304
P3181
P356
10.1007/S00702-014-1216-0
P407
P50
P577
2014-04-22T00:00:00Z
P6179
1008322380